LCE 75 (Carbidopa, entacapone and levodopa 18.75 mg / 200 mg / 75 mg)

Pill imprint LCE 75 has been identified as Carbidopa, entacapone and levodopa 18.75 mg / 200 mg / 75 mg.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 18.75 mg / 200 mg / 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa, entacapone and levodopa

Imprint:

LCE 75

Strength:

18.75 mg / 200 mg / 75 mg

Color:

Red

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.